Asaf Danziger, Chief Executive Officer at NovoCure Ltd (NVCR), sold 17,237 shares at $32.04 ($552K) on 2018-06-20, disclosed to the SEC on 2018-06-21.
Open-market sale of $552k NVCR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.00 | 621 | $20K | 3.6% |
| 2 | $32.04 | 8,308 | $266K | 48.2% |
| 3 | $32.04 | 8,308 | $266K | 48.2% |
| Total | $32.04 avg | 17,237 | $552K | 100% |
| Filing → |
| NVCR | SELL | 2021-04-15 | $38.5M | — | Filing → |
| NVCR | SELL | 2020-12-22 | $61.4M | — | Filing → |
| NVCR | SELL | 2020-09-17 | $10.2M | — | Filing → |